Ocuphire Pharma Shares Outstanding 2010-2024 | IRD
Ocuphire Pharma shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Ocuphire Pharma Annual Shares Outstanding (Millions of Shares) |
2023 |
22 |
2022 |
21 |
2021 |
15 |
2020 |
5 |
2019 |
3 |
2018 |
1 |
2017 |
1 |
2016 |
0 |
2015 |
0 |
2014 |
0 |
2013 |
0 |
2012 |
0 |
2011 |
0 |
2010 |
0 |
2009 |
0 |
Ocuphire Pharma Quarterly Shares Outstanding (Millions of Shares) |
2024-06-30 |
26 |
2024-03-31 |
25 |
2023-12-31 |
22 |
2023-09-30 |
22 |
2023-06-30 |
21 |
2023-03-31 |
21 |
2022-12-31 |
21 |
2022-09-30 |
20 |
2022-06-30 |
20 |
2022-03-31 |
19 |
2021-12-31 |
15 |
2021-09-30 |
17 |
2021-06-30 |
14 |
2021-03-31 |
11 |
2020-12-31 |
5 |
2020-09-30 |
4 |
2020-06-30 |
4 |
2020-03-31 |
4 |
2019-12-31 |
3 |
2019-09-30 |
1 |
2019-06-30 |
1 |
2019-03-31 |
1 |
2018-12-31 |
1 |
2018-09-30 |
1 |
2018-06-30 |
1 |
2018-03-31 |
1 |
2017-12-31 |
1 |
2017-09-30 |
1 |
2017-06-30 |
1 |
2017-03-31 |
0 |
2016-12-31 |
0 |
2016-09-30 |
0 |
2016-06-30 |
0 |
2016-03-31 |
0 |
2015-12-31 |
0 |
2015-09-30 |
0 |
2015-06-30 |
0 |
2015-03-31 |
0 |
2014-12-31 |
0 |
2014-09-30 |
0 |
2014-06-30 |
0 |
2014-03-31 |
0 |
2013-12-31 |
0 |
2013-09-30 |
0 |
2013-06-30 |
0 |
2013-03-31 |
0 |
2012-12-31 |
0 |
2012-09-30 |
0 |
2012-06-30 |
0 |
2012-03-31 |
0 |
2011-12-31 |
0 |
2011-09-30 |
0 |
2011-06-30 |
0 |
2011-03-31 |
0 |
2010-12-31 |
0 |
2010-09-30 |
0 |
2010-06-30 |
0 |
2010-03-31 |
0 |
2009-12-31 |
0 |
2009-09-30 |
0 |
2009-06-30 |
0 |
2009-03-31 |
0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.031B |
$0.019B |
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|